Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Medser AB
AB
Active
Org 5592916141
Medical specialists activities · NACE 8622
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 166K
-16645000% vs 2023
EBITDA margin
33.7%
+117% vs 2023
Equity ratio
11.0%
Financial strength
Net profit 2024
SEK 53K
+117% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 166K
-16645000%
EBITDA
SEK 56K
+117%
Net profit
SEK 53K
+117%
Total assets
SEK 104K
+3714%
Equity
SEK 11K
+128%
Employees
0
—
Company information
Legal name
Medser AB
Org number
5592916141
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
17 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Konsult och utbildningsverksamhet inom medicin, samt handel med värdepapper och därmed förenlig verksamhet.
Contact
Address
Email
robert.levol@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
413
1 159
−0
166
Staff expenses
—
−925
−297
−93
EBITDA
145
192
−328
56
Depreciation & amort.
−0
—
—
—
EBIT
145
192
−328
56
Net financials
—
−0
−12
−3
Profit before tax
110
192
−305
53
Tax
−23
−40
−1
—
Net profit
87
152
−306
53
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
341
668
3
104
Equity
112
265
−41
11
Long-term debt
0
4
16
0
Short-term debt
194
364
28
92
Total debt
194
369
44
92
Financial ratios
5-year trend
EBITDA margin
33.7%
This company
15.8%
Market median
+113% vs market
2021
2024
Equity ratio
11.0%
This company
38.2%
Market median
-71% vs market
2021
2024
Return on equity
461.3%
This company
18.4%
Market median
+2407% vs market
2021
2024
Net profit margin
31.6%
This company
8.1%
Market median
+290% vs market
2021
2024
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
2021
2024
Debt / equity
8.09×
This company
0.62×
Market median
-1205% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KJ
Karl Johan Andres Levol
Deputy Board Member
2022
PR
Priit Robert Levol
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Medser AB also hold positions in
0
other companies.
Person
Role here
Other companies
Karl Johan Andres Levol
Deputy Board Member
0 companies
Priit Robert Levol
Board of Directors
0 companies